Sentences with phrase «of epilepsy treatment»

Schroeder and colleagues have caught this action in monkeys» brains, and more recently, in people implanted with electrodes as part of epilepsy treatment.

Not exact matches

An outside panel of experts gave a resounding thumbs up to GW Pharmaceuticals» cannabis - based experimental treatment for rare, childhood epilepsy and seizure disorders.

It's currently being explored as a potential treatment for certain types of epilepsy as well.

After much research on the Ketogenic Diet, I fine tuned my knowledge of it under the tutelage of the amazing folks at the Charlie Foundation, a non-profit that promotes the use of the Ketogenic Diet in the clinical setting as a non-pharmacological treatment for epilepsy.

There are also a number of medical conditions that should be diagnosed and, if appropriate, treated by a midwife or doctor before you start reflexology treatment, including multiple pregnancies, vaginal discharge, uterine pain, epilepsy, diabetes and any other health problems such as heart, kidney or liver disorders.

Parents of children with severe epilepsy lobbied at the Capitol for the Savino - Gottfried bill, they say it allows for treatment with the oil based derivative shown to help with the condition.

About a dozen conditions are eligible for treatment, including, according to the State Health Department, «severe and debilitating» forms of cancer, HIV, Parkinson's disease and epilepsy.

The bill legalizes medical cannabis as a therapeutic treatment of 10 serious illnesses, including cancer, HIV / AIDS, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, epilepsy, neuropathic diseases and multiple sclerosis.

Parents of children with severe epilepsy lobbied at the state Capitol for the Savino - Gottfried bill, saying it allows for treatment with the oil - based derivative shown to help with the condition.

Savino said 18 states — including New Jersey and Connecticut — have enacted medical marijuana laws to provide relief from diseases or the treatment of diseases such as cancer, multiple sclerosis and epilepsy.

The Romans believed that the fumes produced by burning castoreum could induce an abortion, Paracelsus thought castoreum could be used in the treatment of epilepsy, and medieval beekeepers used it to increase honey production.

This could help treat childhood absence epilepsy patients who experience comorbidities despite successful treatment of seizures.

«But the discovery of this network of genes linked to epilepsy opens avenues for finding new treatments.

It is a minimally invasive procedure that is proving to be a very effective treatment for people with medial temporal lobe epilepsy (MTLE), a common form of drug - resistant epilepsy.

This may provide a potential explanation for why some children with absence epilepsy may have continued deficits in cognitive performance, despite successful treatment of their seizures.

Vincent van Gogh, who suffered from epilepsy, reported seeing rings around lights and halo effects as a direct result of his treatment with digitalis.

Administering the epilepsy drug retigabine opened the potassium channels and counteracted much of the toxin's effects, raising hopes of a treatment for these bites.

Resection of regions implicated in the seizure network is a last - ditch treatment for severe epilepsy; using virtual cortical resection, the researchers could test the impact of targeting the regulatory network instead.

The software and strategies are already being shared openly online by the contest participants, and the unique datasets developed for the competition are being made freely available to researchers worldwide by NINDS, University of Pennsylvania and Mayo Clinic to advance epilepsy research and treatment.

«The findings also suggest that therapies targeting the immune system may be effective treatments against this disorder and possibly other forms of epilepsy,» said Nath.

The scientists hope that new treatment options will open up for epilepsy patients as a result of their discovery.

Since then, a few clinical studies of cannabidiol have also supported its potential as an effective treatment for some forms of epilepsy.

The understandings gained from this research are part of the necessary foundation for developing treatments related to the causes and symptoms of epilepsy.

Since children of mothers with preclinical RA also had an increased risk of epilepsy, Rom said the findings point towards an important role of the disease itself rather than an effect of treatments for RA.

«I hate to say it, but we do not know why» some people respond to medications and others do not, says neurologist Michael Rogawski, who studies epilepsy treatments at the University of California, Davis.

«In the long run, this improved understanding may enable the development of better treatment options for patients suffering from epilepsy.

Today there are at least eight methods, all with their own pros and cons, and some are on the verge of becoming mainstream treatments for Parkinson's disease, epilepsy and depression.

According to Devinsky, 10 to 15 percent of patients with otherwise unmanageable epilepsy are potential candidates for the treatment; clinical trials have shown that the implants reduce seizures in the treated group by an average of as much as 66 percent after three to six years of follow - up.

Around the globe there is high interest in the use of cannabidiol (CBD), a type of cannabinoid, for the treatment of people with epilepsy, especially children who have treatment - resistant forms of the disorder such as Lennox - Gastaut Syndrome (LGS) and Dravet Syndrome (DS).

Importantly, the development of a new animal model for Dravet syndrome based on reduced CHD2 expression might help to find effective treatments that could improve the lives of thousands of people suffering from Dravet syndrome and perhaps other genetic epilepsies.»

Here, the researchers examined brain functions of patients suffering from epilepsy by using methods that coincided with their medical treatment.

A study published ahead of print in the The Journal of General Physiology has revealed new insights into Retigabine, a known pharmacological treatment for epilepsy.

The study is meaningful in respect to the fact that it calls into question the role of the T - type calcium channel in the reticular thalamus, and is expected to provide an important theoretical foundation for understanding its role in the mechanism of absence seizures, as well as developing effective treatment methods for absence epilepsy.

Until recently, 20 to 30 per cent of these patients would develop epilepsy and many need regular antiepileptic treatment.

Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, epilepsy and other life - threatening diseases.

The study examined how many babies were diagnosed with epilepsy and how many are on regular antiepileptic drug treatment at two and four to eight years of age.

A better understanding of the function of neuromodulators, such as COX - 2 and TIA - 1, may help identify novel therapeutic targets for the treatment of epilepsy.»

Even if a lesser severity of perinatal asphyxia is accounted for, cooling therapy has increased the number of healthy survivors and there are very few children with epilepsy needing drug treatment.

Approximately one third of people with epilepsy still experience seizures even when receiving treatment, and currently available anti-epileptic drugs often have side effects such as tiredness and dizziness.

LIVING with epilepsy is hard at the best of times, but in countries where the disorder is poorly understood and treatments are scarce, it can be deadly.

A non-psychoactive compound found in marijuana plants called cannabidivarin (CBDV) has shown promise in the treatment of severe cases of epilepsy.

Around 30 per cent of those with epilepsy don't respond to available treatments.

Similarly the epilepsy studies, including a single randomized trial, found that medical cannabis reduced the frequency of seizures in participants, some with treatment - resistant seizures.

Other groups are exploring different therapeutic applications of optogenetics, including treatments for epilepsy and Parkinson's disease

However, treatment with 1NMPP1 after the prolonged period of seizures prevented epilepsy in the genetically altered but not the normal mice.

There are treatments available for people with temporal lobe epilepsy, including medications to help manage symptoms and, in rarer cases, surgical removal of the temporal lobe, where the seizures originate.

«This study opens a promising new avenue of research into treatments that may prevent the development of epilepsy,» said Vicky Whittemore, PhD, a program director at the National Institute of Neurological Disorders and Stroke, who oversees the grants that funded this study.

«Some GPCRs, for instance, are targeted by neurotransmitters, and their functions are compromised in diseases of the central nervous system, so it is possible that optical switches could also be of interest in the treatment of conditions such as depression or epilepsy.

In a small phase I and II clinical trial, Johns Hopkins researchers and colleagues elsewhere found that the high - fat, low - carbohydrate ketogenic diet was a safe and effective treatment option for the majority of adults experiencing a relatively rare, often fatal and always severe form of epilepsy marked by prolonged seizures that require medically induced comas to prevent them from further damaging the body and the brain.

The ability to temporarily disable or stimulate parts of the brain with the flick of a switch has led researchers to explore DBS in the treatment of several other conditions, including epilepsy, depression, obesity and drug addiction.